Compare
Two peptides, one row at a time.
Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.
Peptide A
Exenatide (Byetta/Bydureon)
verifiedBioGate · GREENGrade B
type 2 diabetes
Peptide B
BPC-157
verifiedBioGate · GREENGrade B
soft-tissue recovery
Identity
- Sequence≠
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSGEPPPGKPADDAGLV - Length≠39 aa15 aa
- Molecular weight≠4186.601419.55
- Modifications≠amidated C-terminus39-residue Heloderma exendin-4acetyl-N-terminus
- Mechanism
GLP-1 receptor agonist derived from Gila monster venom exendin-4; resistant to DPP-4. BID (Byetta) and weekly extended-release (Bydureon) formulations.
Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.
Provenance
- BioGateverifiedBioGate · GREENverifiedBioGate · GREEN
- PDA-V1 outer≠
- Inputs hash≠
- Model versionstructure-fm-2026.04structure-fm-2026.04
- PDA candidates≠24
Outcomes
- RWE cohorts≠45
- Total participants≠259270
- Primary endpoint Δ≠+6.24 Δ HRV ms (8-week)95% CI [4.54, 7.93]-1.7 Δ HRV ms (8-week)95% CI [-2.46, -0.94]
- LOO posterior≠41.1%β(52.7, 75.5)88.1%β(33.8, 4.6)
- Top-grade citations≠Grade B1 of 1Grade B2 of 2
Economics
- IPNFT≠unmintedMolecule IPNFT V2Solana · 73 holders
- Royalty cascade≠-10.04%
Indications
- Listed indications≠
- · type 2 diabetes
- · soft-tissue recovery
- · GI mucosal repair
- · tendon healing